HEARTSEED
Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
HEARTSEED
Industry:
Beauty Biotechnology Health Care Medical Nursing And Residential Care
Founded:
2015-01-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.heartseed.jp
Total Employee:
11+
Status:
Active
Total Funding:
72.04 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Apps For Business Microsoft Azure DNS GMO Internet DNS GMO Internet
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Incubator Japan
Medical Incubator Japan investment in Series C - Heartseed
SMBC Venture Capital
SMBC Venture Capital investment in Series C - Heartseed
Medipal Holdings
Medipal Holdings investment in Series C - Heartseed
Nissay Capital
Nissay Capital investment in Series C - Heartseed
ITOCHU Chemical Frontier
ITOCHU Chemical Frontier investment in Series C - Heartseed
SBI Group
SBI Group investment in Series C - Heartseed
Keio Innovation Initiative
Keio Innovation Initiative investment in Series C - Heartseed
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series C - Heartseed
Sumitomo Mitsui Trust Investment
Sumitomo Mitsui Trust Investment investment in Series C - Heartseed
ITOCHU Chemical Frontier
ITOCHU Chemical Frontier investment in Corporate Round - Heartseed
Official Site Inspections
http://www.heartseed.jp Semrush global rank: 4.03 M Semrush visits lastest month: 3.04 K
- Host name: www8.gmoserver.jp
- IP address: 157.7.144.96
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Heartseed"
Heartseed - Crunchbase Company Profile & Funding
Contact Email [email protected] Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day …See details»
Info Sheet for Technical description - firm.or.jp
Brief Descriptions of Organization* (Approx. 100 words) Heartseed Inc. was founded in 2015 to develop and commercialize cardiac remuscularization therapy developed by Prof. Keiichi …See details»
Heartseed named “Ministry of Education, Culture, Sports, Science …
Feb 10, 2023 To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to …See details»
Heartseed named “Ministry of Education, Culture, Sports, Science …
May 25, 2023 Heartseed plans to use the new funds to complete the Phase 1/2 clinical trial of our lead asset, HS-001 for HF in Japan, as well as to establish an organization for its launch. …See details»
Heartseed Inc. (TYO: 219A) Company Profile & Overview - Stock …
6 days ago Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product candidate is HS-001 for …See details»
Heartseed Company Profile 2024: Stock Performance & Earnings
Heartseed is headquartered in Tokyo, Japan. What is the size of Heartseed? Heartseed has 42 total employees. What industry is Heartseed in? Heartseed’s primary industry is Drug …See details»
Heartseed Inc. | Portfolio | UTokyoIPC - Heartseed Inc. - 東大IPC− ...
In 2015, when the technology development for practical use was complete, he established Heartseed. The company was named Heartseed because cardiomyocyte spheroids …See details»
Heartseed Inc. - LinkedIn
Heartseed Inc. Biotechnology Research Minato-ku, Tokyo 1,668 followers Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart failureSee details»
Heartseed - Overview, News & Similar companies | ZoomInfo.com
Nov 1, 2023 Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure TOKYO--(BUSINESS WIRE)-- #biotech- …See details»
Heartseed Inc. | Portfolio | Keio Innovation Initiative / KII
EN / JP . Portfolio Investment Impact Team Dialogue . Menu. Top News About ... Heartseed has many unique technologies necessary to spread myocardial regenerative medicine, such as the …See details»
Heartseed Company Profile - Office Locations, Competitors, …
Heartseed is a biotechnology company providing iPSC-derived cardiomyocytes for the treatment of heart failure. The company develops and commercializes cardiac regenerative medicine …See details»
Heartseed - Company Profile - Tracxn
Nov 27, 2024 Heartseed - Developer of myocardial regenerative medicine for treating heart diseases. Public Company. Raised a total funding of $76.7M over 5 rounds from 20 investors. …See details»
Heartseed Company Profile: Overview and Full News Analysis
Heartseed is dedicated to advancing groundbreaking science to deliver safe and effective next-generation regenerative therapies. The company has received recognition, including the …See details»
NEWS - heartseed.jp
To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the …See details»
Heartseed - Org Chart, Teams, Culture & Jobs - The Org
View Heartseed's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Heartseed. Information about the issuer. . News and credit ratings ...
Operating organization Address. Seavans South Building 5F, 1-2-3 Shibaura, Minato-ku, Tokyo, 105-0023, Japan Site. https://heartseed.jp/en/ Bond debt by currency. Show more Hide. …See details»
Heartseed selected as “Healthcare Company of the Year 2020
TOKYO, JAPAN, November 30, 2020 – Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of …See details»
Heartseed (Japan) Funding: $86.3M - Medical Startups
Nov 26, 2024 Heartseed is a biotech company developing iPSC-derived highly purified ventricular cardiomyocytes for heart...See details»
Seedtable: Global Startup Database
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»